McDermott Advises Diabeloop SA on its Pioneering Partnership with Roche to Advance Innovation in Treating Diabetes
International law Firm McDermott Will & Emery represented Diabeloop SA in its trailblazing cooperation with Roche Diabetes Care. French-owned Diabeloop SA, a pioneer in therapeutic AI, has entered into a partnership with Roche Diabetes Care, a pioneer in innovative technologies and services in the field of diabetes. This new partnership will enable Diabeloop to accelerate the development and deployment of its DBLG1® automated insulin delivery solution.
McDermott Will & Emery is one of the world’s leading international law firms. It has more than 1,200 lawyers and 20 offices in North America and Europe. As a truly integrated platform, McDermott allows its various teams around the world to work closely and regularly together.